279,972 Shares in Establishment Labs Holdings Inc. (NASDAQ:ESTA) Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. purchased a new stake in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 279,972 shares of the company's stock, valued at approximately $12,898,000. Assenagon Asset Management S.A. owned about 1.00% of Establishment Labs at the end of the most recent quarter.

A number of other hedge funds have also bought and sold shares of the business. Hood River Capital Management LLC bought a new stake in shares of Establishment Labs during the 2nd quarter worth $43,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Establishment Labs during the third quarter worth about $127,000. Nkcfo LLC purchased a new position in Establishment Labs in the second quarter valued at about $227,000. Black Swift Group LLC bought a new position in shares of Establishment Labs during the 3rd quarter valued at approximately $312,000. Finally, Verition Fund Management LLC grew its position in shares of Establishment Labs by 22.8% during the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock valued at $407,000 after acquiring an additional 1,746 shares during the period. 72.91% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. BTIG Research upped their price objective on Establishment Labs from $62.00 to $65.00 and gave the company a "buy" rating in a research note on Monday, October 14th. Stephens upgraded Establishment Labs to a "strong-buy" rating in a research note on Monday, December 2nd. Finally, Citigroup boosted their price objective on Establishment Labs from $45.00 to $50.00 and gave the company a "neutral" rating in a research note on Tuesday, October 1st. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Buy" and an average price target of $60.60.

Establishment Labs Stock Down 0.2 %

Shares of NASDAQ:ESTA traded down $0.08 during midday trading on Friday, reaching $34.56. 685,558 shares of the company traded hands, compared to its average volume of 347,732. Establishment Labs Holdings Inc. has a 12 month low of $30.20 and a 12 month high of $60.12. The firm's fifty day moving average price is $42.96 and its two-hundred day moving average price is $43.42. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.